[Extended spectrum beta lactamase forming bacteria--an increasing and serious problem in ambulatory medicine].
Anagnostopoulos
Alexia
A
Klinik und Poliklinik für Innere Medizin, Universitätsspital Zürich. alexia.anagnostopoulos@usz.ch
Zbinden
R
R
Speck
R
R
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000892:Anti-Infective Agents, Urinary / Q000627:therapeutic use; D001424:Bacterial Infections / Q000188:drug therapy* / Q000382:microbiology*; D003556:Cystitis / Q000188:drug therapy / Q000382:microbiology; D004334:Drug Administration Schedule; D024901:Drug Resistance, Multiple, Bacterial / Q000235:genetics; D016972:Enterobacter cloacae / Q000187:drug effects / Q000201:enzymology / Q000235:genetics; D004926:Escherichia coli / Q000187:drug effects / Q000201:enzymology / Q000235:genetics; D005260:Female; D005838:Genotype; D006801:Humans; D007711:Klebsiella pneumoniae / Q000187:drug effects / Q000201:enzymology / Q000235:genetics; D008826:Microbial Sensitivity Tests; D009582:Nitrofurantoin / Q000627:therapeutic use; D012008:Recurrence; D012307:Risk Factors; D055815:Young Adult; D018440:beta-Lactam Resistance / Q000235:genetics; D001618:beta-Lactamases / Q000235:genetics / Q000378:metabolism*
D000900:Anti-Bacterial Agents; D000892:Anti-Infective Agents, Urinary; D009582:Nitrofurantoin; D001618:beta-Lactamases